Wu said that Huajian Medical (01931 HK) announced that it intends to seek shareholder approval to authorize the purchase of cryptocurrencies for a total amount not exceeding 3 billion Hong Kong dollars within the next 36 months. The company stated that this move aims to strengthen its Ethereum (ETH) reserves and support the ecological development of the ivd xyz trading platform, as part of the group's asset allocation strategy.